MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.medj.2025.100673

Медицинская библиотека · Med (New York, N.Y.) · 2025

Early immune system changes in amyotrophic lateral sclerosis correlate with later disease progression.

Murdock Benjamin J, Zhao Bangyao, Webber-Davis Ian F, Teener Samuel J, Pawlowski Kristen D, Famie Joshua P, Piecuch Caroline E, Jang Dae Gyu, Feldman Eva L, Zhao Lili, Goutman Stephen A

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease with no cure and limited treatment options. The immune system is implicated in disease pathology, unlocking a potential therapeutic avenue. However, it is unclear whether immune changes are a cause or consequence of disease progression.

METHODS

Peripheral immune cells were longitudinally measured at monthly intervals in 55 ALS and 50 control participants. 22 peripheral immune markers in the blood were assessed using flow cytometry, and clinical progression was assessed using the revised ALS functional rating scale (ALSFRS-R). Individual immune markers, their trajectories, and overall variability were compared in ALS versus control participants; ALS participants were also stratified by clinical progression rates and assessed similarly across progression groups. Finally, a novel, lagged linear regression model correlated the rate of immune changes to subsequent downstream ALSFRS-R changes.

FINDINGS: Numerous immune markers were dysregulated in ALS versus control participants, with altered levels, trajectories, or variability in immune populations and surface markers. ALS participants had increased immune variability relative to control participants; within ALS participants, faster progressors overall had decreased marker variability. Finally, natural killer (NK) cell numbers, NK cell subpopulations, and NK cell surface markers were significantly associated with downstream ALS progression.

CONCLUSIONS

The immune system is dysregulated in ALS and more consistently dysregulated in faster ALS progression, and immune dysregulation occurs upstream of clinical changes. These findings suggest that the immune system is a causal factor of ALS progression in human patients.

FUNDING: CReATe Consortium, NIH, Target ALS, DoD, ALSA.

Для цитирования: Murdock Benjamin J, Zhao Bangyao, Webber-Davis Ian F, Teener Samuel J, Pawlowski Kristen D, Famie Joshua P, Piecuch Caroline E, Jang Dae Gyu, Feldman Eva L, Zhao Lili, Goutman Stephen A. Early immune system changes in amyotrophic lateral sclerosis correlate with later disease progression.. Med (New York, N.Y.). 2025. DOI: 10.1016/j.medj.2025.100673.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.